Jimei Holding Group, Beijing, announces its appointment of Dr Dan Zhu as a member of the standing committee and Senior Vice President of the holding group on September 15, 2020. Dr. Zhu will closely work with Mr. Jianguo Zhao, the Founder, Chairman and President of the company, to lead the Sectors of Biomedical Healthcare and Financial Investment in the group.

​

Dr. Zhu will lead to establish a GMP standard production system for stem cells and immune cells, as well as a clinical research and commercial application system in the field of regenerative medicine for chronic disease prevention, treatment, and rehabilitation. He will also be responsible for investing in high-quality technology projects, by utilizing the resources of the National Entrepreneurs Association, which consists of thousands of private enterprises with a total market value exceeding trillions of RMB, and collaborating with renowned investment institutions Meihua Venture Capital and 36Kr to launch venture capital funds.

​

Founded in 1982, Jimei Holding Group has gone through different historical stages such as national reform and opening up, market economy, etc. It has become one of the largest comprehensive industrial private groups in Northern China. It integrates multiple business sectors such as home furnishing market, financial investment, international trade, and biomedical healthcare through wholly-owned, controlling, and equity participation forms.